Efficacy and safety of teneligliptin 40 mg in type 2 diabetes: A pooled analysis of two phase III clinical studies
Diabetes Therapy Feb 16, 2018
Kadowaki T, et al. - Experts sought to investigate the treatment response when the teneligliptin dose was increased from 20 to 40 mg in Japanese patients with type 2 diabetes. A 40 mg/day dosage of teneligliptin proved to be an effective option for treating type 2 diabetes. Such an increase in the dosage was well-tolerated.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries